CD44 and cancer: Recently, it has been reported that suppressing MUC5AC impoverishes cancer cell stemness via interacting with CD44 and affecting pSrc-integrin β4-p53 axis in colorectal cancer19, we wondered whether circRABL2B recapitulated such effect in lung cancer.